Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Avant announces phase II Peru-15 results

Oct. 3, 2002

Two Shionogi patents describe novel immunosuppressant agents

Oct. 2, 2002

Novel immunosuppressants in early development at Sumitomo

Oct. 1, 2002

Positive phase I results for AGI-1096 in prevention of transplant rejection

Oct. 1, 2002

TNX-901 for peanut allergy receives fast track status

Sep. 26, 2002

Tracvax protects against Chlamydia infection in preclinical studies

Sep. 26, 2002

Fujisawa and Pharmagenesis collaborate on triptolide derivatives

Sep. 25, 2002

Beneficial effects on chronic lung rejection reported for switching from ciclosporin to tacrolimus

Sep. 23, 2002

VX-148: a novel IMP dehydrogenase inhibitor with a favorable preclinical profile

Sep. 20, 2002

EMEA grants orphan drug status to APT-070 in kidney transplantation

Sep. 19, 2002

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...